1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6DC2F2A8FAB11B66E00258A1500276A28
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-patient-focused-medical-affairs-excellence-building-medical-patient-teams-engaging-stakeholders-with-insights?opendocument
18
19opendocument
2018.206.194.21
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Patient Advocacy

Patient-Focused Medical Affairs Excellence: Building Medical Patient Teams and Engaging Stakeholders with Patient Experience Insights

ID: 5773


Features:

4 Info Graphics

24 Data Graphics

450+ Metrics

8 Narratives


Pages/Slides: 36


Published: 2023


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Patient-Focused Medical Affairs Excellence: Building Medical Patient Teams and Engaging Stakeholders with Patient Experience Insights”

STUDY OVERVIEW

The role of Medical Affairs has expanded rapidly, reflecting their pivotal role in prioritizing and enhancing the patient experience throughout the entire lifecycle of a product or therapy. Moreover, the increasing demand for data collection and its dissemination to influential thought leaders has propelled Medical Affairs into the forefront of healthcare innovation.

Yet, as patient-centric initiatives continue to evolve, it can be challenging to keep pace with the most effective activities and leverage points specific to Medical’s evolving role in patient-focused activities.

Best Practices, LLC undertook benchmarking research to explore how leading biopharma organizations are building robust Medical patient teams and engaging key stakeholders with patient experience insights. The study probes high-value activities and engagement strategies; impact of patient insights on KOL engagement; direct patient engagement; and Medical’s utilization of patient-reported outcomes.

KEY TOPICS

  • Current Patient-Focused Medical Affairs Landscape
  • Internal and External Impact of Patient-Focused Medical Affairs
  • Informing External Engagement with Patient Experience Insights
  • Medical’s Key Staffing, Resources, and Competencies for Patient Teams

KEY METRICS

  • Overall effectiveness of Medical Affairs organizations in furthering patient-centric goals at biopharma organizations
  • Product types around which Medical teams engage patients or gather patient experience data to inform educational content and strategy
  • Significant challenges for Medical Affairs organizations in driving patient centricity at their companies
  • Medical Affairs organization’s resourcing and management related approaches to driving patient centricity
  • Effective tactics for garnering valuable insights from patients
  • Patient-focused actions resulting in greater impact for Medical Affairs
  • Impact achieved by Medical Affairs when utilizing patient insights for clinical support; KOL and HCP engagement; and patient and advocacy support
  • Impact achieved by Medical Affairs when utilizing patient insights to support other external stakeholders and internal teams and systems
  • Frequency of providing patient experience insights to HCPs
  • Effectiveness of MSLs’ efforts in sharing patient experience data for the purpose of HCP education
  • Direct ways for Medical Affairs personnel to engage with patients and patient groups
  • Engagement frequency with patients or patient representatives
  • Effectiveness of plain language summaries for HCPs and patients
  • Effectiveness of Medical Affairs’ utilization of patient-reported outcomes
  • Total number of Medical Affairs FTEs dedicated to gathering, processing, and implementing patient insights
  • Backgrounds of Medical Affairs staff who are typically responsible for collecting, processing, and implementing patient-oriented programs or tactics
  • Roles of each staff member from Medical patient teams
  • Effectiveness of different backgrounds for Medical patient teams
  • Critical competencies for patient-focused Medical roles
  • Total number of FTEs dedicated to utilizing patient reported outcomes (PROs) or patient reported outcome measures (PROMs)

SAMPLE KEY FINDINGS

  • Medical should create plain language summaries for sales and marketing informed by patient insights, especially those targeted towards patients. While half of Medical organizations share plain language summaries with sales and marketing, half of these respondents report that patient insights have a high impact on the material. This is an additional growth area for Medical to improve performance with patient experience insights and can additionally communicate Medical’s value in patient-focused activities. All Medical organizations who develop plain-language summaries for patients find them effective.

METHODOLOGY

Best Practices, LLC engaged 19 Medical Affairs leaders from 14 biopharma organizations in this benchmarking research.

Industries Profiled:
Medical Device; Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Biopharmaceutical; Health Care; Clinical Research; Laboratories


Companies Profiled:
Baxter International; Bayer; Beiersdorf; DURECT Corporation; Eisai; Eurofarma; LEO Pharma; Merck; Merz Pharma; Novartis; Octave Bio; Pfizer; Sanofi; Teva Pharmaceutical Industries Ltd

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.